港股異動 | 李寧(2331.HK)高開4.23% 股價逼近歷史新高
格隆匯12月11日丨李寧(2331.HK)高開4.23%,報46.85港元,逼近此前11月19日盤中創下的歷史新高47.7港元,暫成交1705萬港元,最新總市值1166億港元,該股今年迄今已累漲超1倍。高盛發研報指,重新對中國運動服飾市場預期作調整,並看好李寧等的前景,維持對行業保守的看法,預期2019至2025年收入年複合增長率可達10%,同時短期復甦強勁的表現令人鼓舞,近月網上銷售增長錄30-50%增長,而線下亦見回升。該行指,維持李寧“買入”評級,目標價升18%至52港元,在該行“最佳情境”假設下,當中反映中國鞋類銷售可達去年美國銷售量,及在中國內地市佔率於2025年升至10%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.